RVPH stock

Reviva Pharmaceuticals Holdings Inc. (RVPH) financials · $7.6M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Reviva Pharmaceuticals Holdings Inc. (RVPH) $7.6M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$20.2M-$30.8M
Net Income-$19.9M-$29.9M
EPS (Diluted)-$5.48-$0.90
Cached annual balance sheet
LineFY2025FY2024
Total Assets$15.9M$15.5M
Current Assets$15.1M$14.7M
Cash & Equivalents$14.4M$13.5M
Total Liabilities$7.28M$14.7M
Current Liabilities$7.28M$14.6M
Short-term Debt$406.9K$458.2K
Total Debt$406.9K$458.2K
Shareholders' Equity$8.65M$812.6K
Retained Earnings-$184.1M-$164.3M

† Total Debt: Derived from short-term debt only (no total or long-term debt stored).

Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$24.6M-$33.5M
Financing Cash Flow$25.6M$23.7M
These statements as JSON? API free 100/day

FAQ

What is RVPH P/E and revenue?

Reviva Pharmaceuticals Holdings Inc. (RVPH) $7.6M cap.

What is RVPH revenue?

RVPH income-statement cache has no revenue figure yet.

Is RVPH profitable?

Reviva Pharmaceuticals Holdings Inc. last cached net income is -$19.9M (FY2025).

What are RVPH total assets?

Reviva Pharmaceuticals Holdings Inc. last cached total assets are $15.9M (FY2025).

What is RVPH free cash flow?

No cached cash-flow row for RVPH yet.

Not investment advice. Cached statements, not a live tape.